Liang Meng, Xiao-Xiao Tian, Xu-Yan Xiang, Xin-Yu Qi, Han-Rong Zhou, Pei-Yu Xiao, Tong-Qing An, Fan-Dan Meng, Hai-Wei Wang
{"title":"Epitope Mapping of Senecavirus A 3A Protein Using Monoclonal Antibodies","authors":"Liang Meng, Xiao-Xiao Tian, Xu-Yan Xiang, Xin-Yu Qi, Han-Rong Zhou, Pei-Yu Xiao, Tong-Qing An, Fan-Dan Meng, Hai-Wei Wang","doi":"10.1155/tbed/3398924","DOIUrl":null,"url":null,"abstract":"<div>\n <p><i>Senecavirus A</i> (SVA), an emerging pathogen causing vesicular disease in pigs, poses a significant threat to the swine industry. The nonstructural protein 3A of SVA plays an essential role in the viral replication cycle. In this study, we immunized mice with the prepared SVA 3A protein and produced two monoclonal antibodies (mAbs), AG4 and 2F3. MAb AG4 showed specific reactivity to the linear and conformational 3A protein, whereas mAb 2F3 did not recognize linear epitope of 3A protein. Through truncated 3A protein expression and alanine mutation analysis, we identified <sup>1</sup>SPNEND<sup>6</sup> as the minimal motif recognized by mAb AG4, with Asn<sup>3</sup> being the critical residue. Additionally, we demonstrated that mAb 2F3 failed to recognize the SVA mutant with the <sup>75</sup>QEETEG<sup>80</sup> deletion in 3A protein, indicating that <sup>75</sup>QEETEG<sup>80</sup> constitutes an essential epitope for mAb 2F3. Further deletion analysis confirmed that <sup>75</sup>QE<sup>76</sup> is the crucial motif for mAb 2F3 recognition. Moreover, we found that <sup>1</sup>SPNEND<sup>6</sup> and <sup>75</sup>QEETEG<sup>80</sup> are highly conserved among different SVA strains and are exposed on the surface of the 3A protein. This study contributes to further explore the function of SVA 3A protein and develop diagnostic tools for SVA detection.</p>\n </div>","PeriodicalId":234,"journal":{"name":"Transboundary and Emerging Diseases","volume":"2025 1","pages":""},"PeriodicalIF":3.5000,"publicationDate":"2025-05-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1155/tbed/3398924","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Transboundary and Emerging Diseases","FirstCategoryId":"97","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1155/tbed/3398924","RegionNum":2,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0
Abstract
Senecavirus A (SVA), an emerging pathogen causing vesicular disease in pigs, poses a significant threat to the swine industry. The nonstructural protein 3A of SVA plays an essential role in the viral replication cycle. In this study, we immunized mice with the prepared SVA 3A protein and produced two monoclonal antibodies (mAbs), AG4 and 2F3. MAb AG4 showed specific reactivity to the linear and conformational 3A protein, whereas mAb 2F3 did not recognize linear epitope of 3A protein. Through truncated 3A protein expression and alanine mutation analysis, we identified 1SPNEND6 as the minimal motif recognized by mAb AG4, with Asn3 being the critical residue. Additionally, we demonstrated that mAb 2F3 failed to recognize the SVA mutant with the 75QEETEG80 deletion in 3A protein, indicating that 75QEETEG80 constitutes an essential epitope for mAb 2F3. Further deletion analysis confirmed that 75QE76 is the crucial motif for mAb 2F3 recognition. Moreover, we found that 1SPNEND6 and 75QEETEG80 are highly conserved among different SVA strains and are exposed on the surface of the 3A protein. This study contributes to further explore the function of SVA 3A protein and develop diagnostic tools for SVA detection.
期刊介绍:
Transboundary and Emerging Diseases brings together in one place the latest research on infectious diseases considered to hold the greatest economic threat to animals and humans worldwide. The journal provides a venue for global research on their diagnosis, prevention and management, and for papers on public health, pathogenesis, epidemiology, statistical modeling, diagnostics, biosecurity issues, genomics, vaccine development and rapid communication of new outbreaks. Papers should include timely research approaches using state-of-the-art technologies. The editors encourage papers adopting a science-based approach on socio-economic and environmental factors influencing the management of the bio-security threat posed by these diseases, including risk analysis and disease spread modeling. Preference will be given to communications focusing on novel science-based approaches to controlling transboundary and emerging diseases. The following topics are generally considered out-of-scope, but decisions are made on a case-by-case basis (for example, studies on cryptic wildlife populations, and those on potential species extinctions):
Pathogen discovery: a common pathogen newly recognised in a specific country, or a new pathogen or genetic sequence for which there is little context about — or insights regarding — its emergence or spread.
Prevalence estimation surveys and risk factor studies based on survey (rather than longitudinal) methodology, except when such studies are unique. Surveys of knowledge, attitudes and practices are within scope.
Diagnostic test development if not accompanied by robust sensitivity and specificity estimation from field studies.
Studies focused only on laboratory methods in which relevance to disease emergence and spread is not obvious or can not be inferred (“pure research” type studies).
Narrative literature reviews which do not generate new knowledge. Systematic and scoping reviews, and meta-analyses are within scope.